AUTOIMMUNE DISEASE DIAGNOSIS MARKET – FORECAST TO 2029
by Product (Instruments, Assay Kits & Consumables), Test Category (Autoantibodies and Immunologic, Routine Laboratory, Inflammatory Markers), Diagnosis (Complete Blood Count, C-reactive Protein, Antinuclear Antibody, Autoantibody, Urinalysis, Others),Disease (Scleroderma, Thyroiditis, RA, SLE, Others), Application (Clinical Labs, Hospitals) and Region – Global Forecast to 2029.
The Autoimmune Disease Diagnosis Market, in terms of value, is projected to grow at a CAGR of XX% from 2023 to 2029. The market is estimated to be USD XX Billion in 2023, & is projected to reach XX Billion by 2029. In this study, 2023 has been considered the base year & 2023 to 2029 the forecast period, for estimating the market size of the global market.
Covid -19 crisis impacted the Autoimmune Disease Diagnosis Market. The supply of raw material halted for long as Covid -19 pandemic had broken the most of transportation links and distribution mechanisms. By region, Asia Pacific is expected to capture the largest market share during the forecast period.
Comprehensive Coverage of Applications and Geographical Segments.
By Product:
Instruments
Assay Kits & Consumables
By Test Category:
Autoantibodies and Immunologic
Routine Laboratory
Inflammatory Markers
By Diagnosis:
Complete Blood Count
C-reactive Protein
Antinuclear Antibody
Autoantibody
Urinalysis
Others
By Disease:
Scleroderma
Thyroiditis
RA
SLE
Others
By Product:
Clinical Labs
Hospitals
By Region:
Asia Pacific
Europe
North America
South America
Middle East & Africa
What will you get from the report:
– Market Insights and Overview
– Trends and Forecast up to 2029.
– Major Segments covering applications and geographies.
– Competitive Landscape & Key players.